Cosmo N.V. (LON:0RGI)

Market Cap	872.41M -9.0%
Revenue (ttm)	88.42M -43.7%
Net Income	-5.47M
EPS	-0.33
Shares Out	n/a
PE Ratio	n/a
Forward PE	899.85
Dividend	1.81 (3.62%)
Ex-Dividend Date	Apr 24, 2026

Volume	2,577
Open	56.00
Previous Close	57.00
Day's Range	55.20 - 56.60
52-Week Range	54.80 - 129.60
Beta	1.48
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 23, 2026

About Cosmo

Cosmo N.V., a life sciences company, develops and manufactures pharmaceuticals and contracts for gastroenterology, dermatology, and health tech in Ireland and internationally. The company offers GI Genius, a computer-assisted system that uses artificial intelligence in real time to detect colorectal lesions; Winlevi, a prescription medicine used on the skin to treat acne vulgaris; Lialda/Mezavant/Mesavancol, a once-daily mesalamine tablet approved to help get active, mild to moderate ulcerative colitis into remission; Uceris/Cortiment, an oral ...

• Industry: Medical - Pharmaceuticals
• Sector: Healthcare
• Founded: 1997
• Employees: 365
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0RGI

Financial Performance

Financial numbers in EUR

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Sep 3, 2026

Data Sources Report a data error